In their CMAJ article, Drs. Palis and MacDonald1 advocate for expanded util ization of
prescribed psychostimulants as a treatment option within the care continuum for people with …

Physicians have traditionally asked about substance use within the Social History section of
the consultation note. Drawing on social science theory and using the authors' own …

Objectives Psychostimulant-related mortality is rising alongside increasing substance use-
related hospitalizations, which are commonly complicated by patient-directed (or “against …

Introduction Illicit stimulant (cocaine and/or amphetamine) use among young people aged
12–24 is a public health priority given that substance use initiation tends to peak in this …

Perry and colleagues presented key recommendations from joint guidelines from the US
Department of Veterans Affairs and the US Department of Defense for management of …

Background and aims A 12‐week placebo‐controlled, sequential parallel Accelerated
Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder …

Background Increases in US older adults' nonprescription opioid and psychostimulant use
call for examining their treatment admissions for these substances. Methods Using …

Introduction Methadone maintenance therapy (MMT) has been a pillar of opioid addiction
treatment. Opioid treatment programs (OTPs) have been faced with an escalating threat of …

Purpose The rise of fatal stimulant use among adults who use opioids is a public health
problem. Internalized stigma is a barrier to substance use treatment, which is greater for …

Background Factors that predict attempts to discontinue drug use are clinically relevant and
may inform treatment. This study investigated drug use-related consequences as a predictor …